ENvue Medical, Inc.
FEED- Exchange
- OTC
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001326706
No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in ENvue Medical, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −1 vs. Q4 2023
- Shares held
- 363.6K
- +256.3K (+238.9%) vs. Q4 2023
- Total value
- $327.2K
- +$204.2K (+166.0%) vs. Q4 2023
- New holders
- 2
- 2 more added
- Sold out
- 3
- 1 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FEED on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $149.2K |
| Q1 2026 | 13 | $179.2K |
| Q4 2025 | 6 | $42.5K |
| Q3 2025 | 6 | $9.50K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 9 | $215.3K |
| Q3 2024 | 9 | $251.5K |
| Q2 2024 | 8 | $163.3K |
| Q1 2024 | 10 | $327.2K |
| Q4 2023 | 11 | $123.0K |
| Q3 2023 | 13 | $242.1K |
| Q2 2023 | 9 | $142.1K |
| Q1 2023 | 10 | $203.6K |
| Q4 2022 | 18 | $593.0K |
| Q3 2022 | 15 | $679.0K |
| Q2 2022 | 13 | $906.0K |
| Q1 2022 | 19 | $2.12M |
| Q4 2021 | 20 | $1.72M |
| Q3 2021 | 21 | $2.60M |
| Q2 2021 | 17 | $954.1K |
| Q1 2021 | 14 | $1.17M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding ENvue Medical, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 250,899 | $225.8K | 0.01% | +250,899 | New |
| Renaissance Technologies LLC | 38,862 | $35.0K | 0.00% | −2,338−5.7% | Reduced |
| Vanguard Group Inc | 30,194 | $27.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 14,461 | $13.0K | 0.00% | 00.0% | Unchanged |
| Amtrust Financial Services, Inc. | 12,408 | $11.2K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,650 | $9.56K | 0.00% | +10,650 | New |
| Tower Research Capital LLC (TRC) | 6,057 | $5.45K | 0.00% | +795+15.1% | Added |
| Wells Fargo & Company | 16 | $14 | 0.00% | +3+23.1% | Added |
| Morgan Stanley | 10 | $9 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1 | $1 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −3,537−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −74−100.0% | Sold out |